INTRANAZAL'NYE GLYuKOKORTIKOSTEROIDY V LEChENII PATsIENTOV S POLIPOZNYM RINOSINUSITOM


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article summarizes the current state of the problem of polypoid rhinosinusitis. The potentials for the use of intranasal glucocortico-steroids in the treatment of such patients are discussed. A number of advantages of budesonide are characterized by a pharmacological parameters, allowing effective and safe control of clinical symptoms of polypoid rhinosinusitis.

Texto integral

Acesso é fechado

Bibliografia

  1. Сакович А.Р. Синуситы: клинико-эпидемиологический анализ. 2009. Доступно на: http://bsmu.by/index.php?option=com_ content&view=artide&id= 1603:2009-10-13-09-17-50&catid=116:32009&itemid=196
  2. Desrosiers M., Evans G.A., Keith P.K., et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin. immunol. 2011;7(1):2.
  3. Fokkens W.J, Lund V.J., Mullol J. et al. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2007;45(20):1-139.
  4. Fokkens W.J., Lund V.J., Mullol J., et al., European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2012;50(23):1-299.
  5. Крюков А.И., Туровский А.Б., Сединкин А.А. Диагностика и лечение полипозного синусита. РМЖ 2011;6:377-80.
  6. Княжеская Н.П., Чучалин А.Г. Ингаляционные глюкокортикостероиды (ИГКС) - основа противовоспалительной терапии бронхиальной астмы. Эффективность, безопасность и области применения суспензии Пульмикорт (будесонид). РМЖ. 2008;22:1515-19.
  7. Brattsand R., Miller-Larsson A. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity. Clin. Ther. 2003;25:28-41.
  8. Derom E. et al. Systemic Effects of inhaled Fluticasone Propionate and Budesonide in Adult Patients with Asthma. Am. J. Respir. Crit. Care Med. 1999;160:157-61.
  9. Kallen B., Rydhstroem H., Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93(3):392-95.
  10. Miller-Larsson A., et al. Reversible fatty acid conjugation of budesonide. Novel Mechanism for Prolonged Retention of Topically Applied Steroid in Airway Tissue. Drug Metabolism and Disposition. 1998;26: 623-30.
  11. Miller-Larsson A., et al. Prolonged Airway Activity and improved Selectivity of Budesonide Possibly Due to Esterification. Am. J. Respir. Crit. Care Med. 2000;162:1455-61.
  12. Pedersen S., O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroides in asthma. Allergy. 1997;52(Suppl. 39):1-34.
  13. Белоусов Ю.Б., Моисеев В.С., Лепахин В.К. Клиническая фармакология и фармакотерапия. М., 1997.
  14. Сергеев П.В., Галенко-Ярошевский П.А., Шимановский Н.Л. Очерки биохимической фармакологии. М., 1996.
  15. Kallen B., Rydhstroem H., Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392-95.
  16. Kim K.T., Rabinovitch N., Uryniak T., Simpson B., O'Dowd L., Casty F. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Ann Allergy Asthma immunol. 2004;93:61-7.
  17. FDA Pregnancy Labeling Task Force http:// www.fda.gov/cder/handbook/categc.htm
  18. Yawn B. Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy. J. Am. Board Fam. Med. 2007;20:289-98.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies